Wai Hong Wilson Tang, MD

W. H. Wilson Tang, MD, is Research Director, and staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at the Cleveland Clinic.  Dr. Tang is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. 

In addition to office visits, Dr. Tang also offers scheduled follow up virtual visits to select patients, through the Cleveland Clinic Express Care ® Online app. This platform allows patients to see their physician live, using their smartphone, tablet or computer.

Specialty Interests:  Dr. Tang’s specialty interests include cardiomyopathy, heart failure including heart transplantation and mechanical circulatory assist devices, cardio-renal diseases, and cancer-related heart diseases.

Number of Procedures performed:  Dr. Tang has performed hemodynamic assessments by right heart catheterization, endomyocardial biopsies, and invasive and non-invasive cardiopulmonary exercise testing over the past two decades.

Education and Training:  Dr. Tang graduated magna cum laude with a Bachelor of Science degree in neural sciences from Brown University in Rhode Island, where he matriculated at Jesus College, Cambridge University, in England for an honorary one-year period of study in molecular medicine.  Dr. Tang received his medical degree from Harvard Medical School, and completed his internship and residency in internal medicine, and a research fellowship in heart failure at Stanford University Medical Center. This was followed by clinical cardiology fellowship training at the Cleveland Clinic, and an advanced clinical fellowship in heart failure and cardiac transplantation. He was appointed to Cleveland Clinic in 2004 as a Staff Physician in the Section of Heart Failure and Cardiac Transplantation Medicine. Dr. Tang is board-certified in internal medicine, cardiovascular medicine, and advanced heart failure and transplant cardiology. He currently serves as member of the Board of Directors of the Heart Failure Society of America.

Research and Publications: Dr. Tang is a clinician-scientist interested in clinical translational research, with joint appointments with the Department of Cellular and Molecular Medicine and the Genomic Medicine Institute at Cleveland Clinic's Lerner Research Institute.  He leads the Cleveland GeneBank Study as well as the Cleveland Heart and Metabolic Prevention Study to investigate novel mechanisms in the development of heart diseases.  Dr. Tang also has leadership role in the National Institutes of Health (NIH)-sponsored Clinical and Translational Sciences Collaborative, overseeing the Hub Research Capacity and directs the Cleveland Clinic Clinical Research Unit.  Dr. Tang’s current research interests include the role of counter-regulatory mechanisms in the development and progression of heart failure, integrative genomics and epigenetics in cardiomyopathies, and metabolomics in cardio-renal physiology.  Dr. Tang has authored over 630 published peer-reviewed manuscripts in medical and scientific journals and chapters in medical textbooks. He currently serves in the Editorial Boards for Journal of the American College of Cardiology (JACC) Heart Failure, JACC Cardio-Oncology, Circulation Heart Failure, and American Heart Journal.  He was elected as member of the American Society of Clinical Investigation (ASCI) in 2013 and Association of American Physicians (AAP) in 2018, both national honor societies for physician scientists for his contributions in medical research. 

About Dr. Tang: "It is a privilege to make a significant impact in someone’s life, and to discover new and better ways to take care of them."

Leisure time activities: Dr. Tang enjoys traveling and spending time with his family.